{"id":5861,"date":"2017-02-14T08:40:15","date_gmt":"2017-02-14T13:40:15","guid":{"rendered":"https:\/\/medicarereport.org\/?p=5861"},"modified":"2017-02-14T08:40:15","modified_gmt":"2017-02-14T13:40:15","slug":"drugmaker-marathon-pausing-delivery-of-89000-a-year-muscular-dystrophy-drug","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=5861","title":{"rendered":"Drugmaker Marathon \u2018Pausing\u2019 Delivery Of $89,000-a-year Muscular Dystrophy Drug"},"content":{"rendered":"<p>(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News)<\/p>\n<p>In a surprise move Monday, Marathon Pharmaceuticals told patient advocates that it would \u201cpause\u201d the launch of its drug Emflaza because of pricing concerns expressed by patients and advocacy groups. <a href=\"http:\/\/khn.org\/news\/drugmaker-marathon-pausing-delivery-of-89000-a-year-muscular-dystrophy-drug\/?utm_campaign=KHN%3A+First+Edition&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=42563340&amp;_hsenc=p2ANqtz-9w0SltJyQwo7POlewou4CuBsWKPdK32CrPjtspKWfZuL5RzHgaQFU35DpMSO8I3H1Xk0EB20pieoCFiC58KCq_OvF4OQ&amp;_hsmi=42563340\" target=\"_blank\">Continue reading article here&#8230;<\/a><\/p>\n<p style=\"margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; line-height: 1.6; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', serif; font-size: 15px; font-style: normal; font-weight: normal; word-spacing: 0px; vertical-align: baseline; white-space: normal; orphans: 2; widows: 2; font-stretch: inherit; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; -webkit-text-stroke-width: 0px;\">Kaiser Health News\u00a0is\u00a0a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n<p style=\"margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; line-height: 1.6; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', serif; font-size: 15px; font-style: normal; font-weight: normal; word-spacing: 0px; vertical-align: baseline; white-space: normal; orphans: 2; widows: 1; font-stretch: inherit; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; -webkit-text-stroke-width: 0px;\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-899 \" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png\" alt=\"khn-logo1\" width=\"92\" height=\"48\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-1024x533.png 1024w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-390x205.png 390w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png 1600w\" sizes=\"auto, (max-width: 92px) 100vw, 92px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Sarah Jane Tribble and Sydney Lupkin for Kaiser Health News) In a surprise move Monday, Marathon Pharmaceuticals told patient<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-5861","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/5861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5861"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/5861\/revisions"}],"predecessor-version":[{"id":5862,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/5861\/revisions\/5862"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}